venBio Global Strategic Fund III, L.P.'s Net Worth
$15.6 Million
Who is venBio Global Strategic Fund III, L.P.?
venBio Global Strategic Fund III, L.P. has an estimated net worth of $15.6 Million. This is based on reported shares across multiple companies, which include RayzeBio, Inc., Ventyx Biosciences, Inc., Elevation Oncology, Inc., and Artiva Biotherapeutics, Inc..
SEC CIK
venBio Global Strategic Fund III, L.P.'s CIK is 0001739920
Past Insider Trading and Trends
2021 was venBio Global Strategic Fund III, L.P.'s most active year for acquiring shares with 4 total transactions. venBio Global Strategic Fund III, L.P.'s most active month to acquire stocks was the month of June. 2021 was venBio Global Strategic Fund III, L.P.'s most active year for disposing of shares, totalling 3 transactions. venBio Global Strategic Fund III, L.P.'s most active month to dispose stocks was the month of August. 2021 saw venBio Global Strategic Fund III, L.P. paying a total of $15,000,000.00 for 6,605,436 shares, this is the most they've acquired in one year. In 2022 venBio Global Strategic Fund III, L.P. cashed out on 702,737 shares for a total of $2,897,806.29, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RayzeBio, Inc. (RYZB) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.16M |
—
|
—
| 5.16M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.0801
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 4M |
$16.00 |
—
| 4M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Elevation Oncology, Inc. (ELEV) Snapshot price: $0.6896
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.94% | -702.74K |
$4.12 | -$2,897,806.29 | 1.91M |
May 25
| |||
Form 4
|
∞
| 2.61M |
$16.00 |
—
| 2.61M |
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Artiva Biotherapeutics, Inc. (ARTV) Snapshot price: $11.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.94M |
$12.00 |
—
| 1.94M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||